Zenlabs Ethica has entered into a business agreement with V Nexxtra Lifesciences to appoint V Nexxtra Lifesciences as its sole and exclusive distributor for the entire territory, for the sale, marketing promotion and distribution of the entire portfolio of products of Zenlabs Ethica and its subsidiaries, on the terms and conditions contained in this agreement.
V Nexxtra Lifesciences shall also be responsible for sales planning, forecasting, market development, collection of orders and payments and ensuring compliance with all applicable laws, rules, regulations, and other statutory requirements relating to the marketing, distribution and sale of the products. Further, V Nexxtra Lifesciences shall be the sole agent for the Zenlabs Ethica only, shall not be indulged in the similar activities of marketing and promotion of any other company without mutual consent or approval from Zenlabs Ethica. V Nexxtra Lifesciences shall pay Zenlabs Ethica margin at the rate of 5% of the Net Sales Value of Zenlabs Ethica (exclusive of GST), payable on or before the 10th day of the succeeding month along with the relevant sales/purchase statement.
The objective of agreement is to strengthen the company's sales and distribution network enhance market penetration, and improve customer reach through a dedicated and specialized marketing channel.
Zenlabs Ethica offers various types of branded drugs that are manufactured by Zenlabs Pharmaceuticals Inc., strictly as per the prescribed international standards and norms.
| Company Name | CMP |
|---|---|
| Redington | 348.25 |
| Amrapali Industries | 35.01 |
| Adani Enterprises | 2977.70 |
| Rashi Peripheral | 865.00 |
| PDS | 371.95 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: